Aging research often finds that drastically cutting calories extends lifespan across species—but caloric restriction is hard for humans to sustain. Scientists have long sought alternative ways to trigger the same longevity-promoting pathways without starving. This study explores an unexpected candidate: LSD, the psychedelic drug, which has recently attracted scientific interest for mental health applications. The researchers asked whether LSD might also engage aging-related biology.
The team treated C. elegans (tiny nematode worms, a standard aging model) with LSD and measured lifespan, cellular aging markers, body size, reproduction, and nutrient-sensing signaling. They found LSD extended lifespan and reduced lipofuscin ("age pigment" that accumulates with aging), suggesting slowed cellular decay. Notably, LSD mimicked several hallmarks of caloric restriction: reduced reproduction, smaller body size, and altered lipid metabolism. Importantly, LSD did *not* additively extend lifespan when combined with dietary restriction, suggesting it may work through overlapping pathways rather than a novel mechanism.
The findings are genuinely interesting from a mechanistic perspective: they hint that serotonergic signaling (LSD's primary mode) might regulate nutrient-sensing pathways (TOR/mTOR) linked to aging. This could open new research directions on how brain chemistry influences longevity biology. However, this is a single study in a simple organism with zero replication, no human data, and no dose-response characterization. The abstract doesn't clarify whether behavioral changes from the drug (rather than direct molecular effects) drive the lifespan extension—a critical distinction for mechanism.
A major limitation is that this is a preprint: it has not yet undergone peer review. Preprints are often preliminary and can contain errors or overstatements. The sample size (number of worms tested) is not specified in the abstract. Additionally, the leap from worm lifespan to human longevity is enormous; most compounds that extend C. elegans lifespan fail in mammals, let alone humans. The practical relevance is also unclear—LSD's psychoactive effects at life-extending doses remain unknown.
For the longevity field, this work is a thought-provoking signal worth following up, especially given renewed scientific interest in psychedelics. It could catalyze research on serotonin's role in aging or inspire new compounds targeting the same pathways with fewer side effects. However, we are at the very earliest stage of inquiry. This is a hypothesis-generating study, not evidence for LSD as a geroprotector.
0 Comments
Log in to join the discussion.